Antidiabetic activities of chitosan and its derivatives. A mini review.

Advances in Food and Nutrition Research

Volumn 73, Issue , 2014, Pages 33-44

  Karadeniz, Fatih ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Chitosan; Chitosan oligosaccharides; Diabetes; Glucosamine

Indexed keywords

ANTIDIABETIC AGENT; ANTIOBESITY AGENT; CHITOSAN;

ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; HUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-OBESITY AGENTS; CHITOSAN; HUMANS; HYPOGLYCEMIC AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84908051828     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800268-1.00003-2     Document Type: Chapter

References (57)

1. Artan M., Karadeniz F., Karagozlu M.Z., Kim M.M., Kim S.K. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydrate Research 2010, 345(5):656-662.
2. Cho Y.S., Lee S.H., Kim S.K., Ahn C.B., Je J.Y. Aminoethyl-chitosan inhibits LPS-induced inflammatory mediators, INOS and COX-2 expression in RAW264.7 mouse macrophages. Process Biochemistry 2011, 46(2):465-470.
3. Cho E.J., Rahman M.A., Kim S.W., Baek Y.M., Hwang H.J., Oh J.Y., et al. Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. Journal of Microbiology and Biotechnology 2008, 18(1):80-87.
4. Fenton J.I., Chlebek-Brown K.A., Peters T.L., Caron J.P., Orth M.W. The effects of glucosamine derivatives on equine articular cartilage degradation in explant culture. Osteoarthritis and Cartilage 2000, 8(6):444-451.
5. Fernandez-Urrusuno R., Calvo P., Remunan-Lopez C., Vila-Jato J.L., Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharmaceutical Research 1999, 16(10):1576-1581.
6. Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology 2002, 81(1):81-100.
7. Hai L., Bang Diep T., Nagasawa N., Yoshii F., Kume T. Radiation depolymerization of chitosan to prepare oligomers. Nuclear Instruments & Methods in Physics Research Section B Beam Interactions with Materials and Atoms 2003, 208:466-470.
8. Hari P.R., Chandy T., Sharma C.P. Chitosan/calcium-alginate beads for oral delivery of insulin. Journal of Applied Polymer Science 1996, 59(11):1795-1801.
9. Hernandez-Gonzalez S.O., Gonzalez-Ortiz M., Martinez-Abundis E., Robles-Cervantes J.A. Chitosan improves insulin sensitivity as determined by the euglycemic-hyperinsulinemic clamp technique in obese subjects. Nutrition Research 2010, 30(6):392-395.
10. Huang M., Khor E., Lim L.Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharmaceutical Research 2004, 21(2):344-353.
11. Huang R., Mendis E., Kim S.K. Factors affecting the free radical scavenging behavior of chitosan sulfate. International Journal of Biological Macromolecules 2005, 36(1-2):120-127.
12. Ihara Y., Toyokuni S., Uchida K., Odaka H., Tanaka T., Ikeda H., et al. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 1999, 48(4):927-932.
13. Il'ina A.V., Varlamov V.P. Hydrolysis of chitosan in lactic acid. Applied Biochemistry and Microbiology 2004, 40(3):300-303.
14. Ivorra M.D., Paya M., Villar A. A review of natural products and plants as potential antidiabetic drugs. Journal of Ethnopharmacology 1989, 27(3):243-275.
15. Jameela S.R., Misra A., Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. Journal of Biomaterials Science Polymer Edition 1994, 6(7):621-632.
16. Je J.Y., Kim S.K. Chitosan derivatives killed bacteria by disrupting the outer and inner membrane. Journal of Agricultural and Food Chemistry 2006, 54(18):6629-6633.
17. Jeon Y.J., Kim S.K. Production of chitooligosaccharides using an ultrafiltration membrane reactor and their antibacterial activity. Carbohydrate Polymers 2000, 41(2):133-141.
18. Jiang L., Qian F., He X., Wang F., Ren D., He Y., et al. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice. The Journal of Gene Medicine 2007, 9(4):253-264.
19. Kanauchi O., Deuchi K., Imasato Y., Shizukuishi M., Kobayashi E. Mechanism for the inhibition of fat digestion by chitosan and for the synergistic effect of ascorbate. Bioscience Biotechnology and Biochemistry 1995, 59(5):786-790.
20. Karadeniz F., Artan M., Kong C.S., Kim S.K. Chitooligosaccharides protect pancreatic β-cells from hydrogen peroxide-induced deterioration. Carbohydrate Polymers 2010, 82(1):143-147.
21. Kendra D.F., Hadwiger L.A. Characterization of the smallest chitosan oligomer that is maximally antifungal to Fusarium solani and elicits pisatin formation in Pisum sativum. Experimental Mycology 1984, 8(3):276-281.
22. Kim J.H., Kim Y.S., Park K., Lee S., Nam H.Y., Min K.H., et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. Journal of Controlled Release 2008, 127(1):41-49.
23. Kim J.A., Kong C.S., Pyun S.Y., Kim S.K. Phosphorylated glucosamine inhibits the inflammatory response in LPS-stimulated PMA-differentiated THP-1 cells. Carbohydrate Research 2010, 345(13):1851-1855.
24. Kim S.K., Park P.J., Jung W.K., Byun H.G., Mendis E., Cho Y.I. Inhibitory activity of phosphorylated chitooligosaccharides on the formation of calcium phosphate. Carbohydrate Polymers 2005, 60(4):483-487.
25. Kim S.K., Rajapakse N. Enzymatic production and biological activities of chitosan oligosaccharides (COS): A review. Carbohydrate Polymers 2005, 62(4):357-368.
26. Kochkina Z.M., Chirkov S.N. Effect of chitosan derivatives on the development of phage infection in cultured Bacillus thuringiensis. Mikrobiologiia 2000, 69(2):266-269.
27. Kondo Y., Nakatani A., Hayashi K., Ito M. Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice. Biological & Pharmaceutical Bulletin 2000, 23(12):1458-1464.
28. Kong C.S., Kim J.A., Bak S.S., Byun H.G., Kim S.K. Anti-obesity effect of carboxymethyl chitin by AMPK and aquaporin-7 pathways in 3T3-L1 adipocytes. The Journal of Nutritional Biochemistry 2011, 22(3):276-281.
29. Kong C.S., Kim J.A., Kim S.K. Anti-obesity effect of sulfated glucosamine by AMPK signal pathway in 3T3-L1 adipocytes. Food and Chemical Toxicology 2009, 47(10):2401-2406.
30. Koping-Hoggard M., Tubulekas I., Guan H., Edwards K., Nilsson M., Varum K.M., et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Therapy 2001, 8(14):1108-1121.
31. Koski R.R. Oral antidiabetic agents: A comparative review. Journal of Pharmacy Practice 2004, 17(1):39-48.
32. Krauland A.H., Guggi D., Bernkop-Schnurch A. Oral insulin delivery: The potential of thiolated chitosan-insulin tablets on non-diabetic rats. Journal of Controlled Release 2004, 95(3):547-555.
33. Krauland A.H., Guggi D., Bernkop-Schnurch A. Thiolated chitosan microparticles: A vehicle for nasal peptide drug delivery. International Journal of Pharmaceutics 2006, 307(2):270-277.
34. Kuroiwa T., Ichikawa S., Hiruta O., Sato S., Mukataka S. Factors affecting the composition of oligosaccharides produced in chitosan hydrolysis using immobilized chitosanases. Biotechnology Progress 2002, 18(5):969-974.
35. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacological Research 2006, 53(6):482-491.
36. Leong K.S., Wilding J.P. Obesity and diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 1999, 13(2):221-237.
37. Li W., Zheng H., Bukuru J., De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004, 92(1):1-21.
38. Liu T.Y., Lin Y.L. Novel pH-sensitive chitosan-based hydrogel for encapsulating poorly water-soluble drugs. Acta Biomaterialia 2010, 6(4):1423-1429.
39. Liu B., Liu W.S., Han B.Q., Sun Y.Y. Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World Journal of Gastroenterology 2007, 13(5):725-731.
40. Ma Z., Lim T.M., Lim L.Y. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. International Journal of Pharmaceutics 2005, 293(1-2):271-280.
41. Maezaki Y., Tsuji K., Nakagawa Y., Kawai Y., Akimoto M., Tsugita T., et al. Hypocholesterolemic effect of chitosan in adult males. Bioscience Biotechnology and Biochemistry 1993, 57(9):1439-1444.
42. Mao S., Germershaus O., Fischer D., Linn T., Schnepf R., Kissel T. Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharmaceutical Research 2005, 22(12):2058-2068.
43. Neyrinck A.M., Bindels L.B., De Backer F., Pachikian B.D., Cani P.D., Delzenne N.M. Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action. International Immunopharmacology 2009, 9(6):767-773.
44. Nishimura S.I., Kai H., Shinada K., Yoshida T., Tokura S., Kurita K., et al. Regioselective syntheses of sulfated polysaccharides: Specific anti-HIV-1 activity of novel chitin sulfates. Carbohydrate Research 1998, 306(3):427-433.
45. Portero A., Teijeiro-Osorio D., Alonso M.J., Remuñán-López C. Development of chitosan sponges for buccal administration of insulin. Carbohydrate Polymers 2007, 68(4):617-625.
46. Prabaharan M. Chitosan derivatives as promising materials for controlled drug delivery. Journal of Biomaterials Applications 2008, 23(1):5-36.
47. Qin C., Li H., Xiao Q., Liu Y., Zhu J., Du Y. Water-solubility of chitosan and its antimicrobial activity. Carbohydrate Polymers 2006, 63(3):367-374.
48. Remunan-Lopez C., Portero A., Vila-Jato J.L., Alonso M.J. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. Journal of Controlled Release 1998, 55(2-3):143-152.
49. Sato T., Ishii T., Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001, 22(15):2075-2080.
50. Schoninger L.M., Dall'Oglio R.C., Sandri S., Rodrigues C.A., Burger C. Chitosan iron(III) reduces phosphorus levels in alloxan diabetes-induced rats with signs of renal failure development. Basic & Clinical Pharmacology & Toxicology 2010, 106(6):467-471.
51. Tanaka Y., Tanioka S., Tanaka M., Tanigawa T., Kitamura Y., Minami S., et al. Effects of chitin and chitosan particles on Balb/c mice by oral and parenteral administration. Biomaterials 1997, 18(8):591-595.
52. Thanou M., Verhoef J.C., Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Advanced Drug Delivery Reviews 2001, 52(2):117-126.
53. Vinik A.I., Maser R.E., Mitchell B.D., Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003, 26(5):1553-1579.
54. Vongchan P., Sajomsang W., Subyen D., Kongtawelert P. Anticoagulant activity of a sulfated chitosan. Carbohydrate Research 2002, 337(13):1239-1242.
55. Wang W., Lin S., Xiao Y., Huang Y., Tan Y., Cai L., et al. Acceleration of diabetic wound healing with chitosan-crosslinked collagen sponge containing recombinant human acidic fibroblast growth factor in healing-impaired STZ diabetic rats. Life Sciences 2008, 82(3-4):190-204.
56. Xie W., Xu P., Liu Q. Antioxidant activity of water-soluble chitosan derivatives. Bioorganic & Medicinal Chemistry Letters 2001, 11(13):1699-1701.
57. Yamauchi T., Waki H., Kamon J., Murakami K., Motojima K., Komeda K., et al. Inhibition of RXR and PPAR-gamma ameliorates diet-induced obesity and type 2 diabetes. The Journal of Clinical Investigation 2001, 108(7):1001-1013.